We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nosocomial Infection Increases Length of Stay

By HospiMedica International staff writers
Posted on 22 Dec 2011
Hospital-acquired Clostridium difficile infection increases length of stay in hospital by an average of six days. More...


C. difficile is the most common cause of infectious diarrhea in hospital, and it is estimated that 10% of patients who become infected in hospital will die.

Scientists performed a retrospective observational cohort study analyzing data on 136, 877 admissions to the Ottawa Hospital (ON, Canada) between July 1, 2002, and March 31, 2009. A total of 1,393 patients acquired C. difficile in hospital during this time, and these patients spent 34 days in hospital compared with eight days for patients who did not have C. difficile. However, the investigators also found that patients who became infected with C. difficile tended to have illnesses that are more serious and would have been more likely to stay longer in hospital anyway. When they controlled for the level of illness using a mathematical model, they found that hospital-acquired C. difficile increased the length of stay in hospital by six days.

In adjusted analyses, hospital-acquired C. difficile was significantly associated with time to discharge, modified by baseline risk of death and time to acquisition of C. difficile. Alan J Forster, MD MSc, a senior scientist at the Ottawa Hospital Research Institute, said "We believe our study provides the most accurate measure yet of the impact of hospital-acquired C. difficile on length of hospital stay. C. difficile is a very serious problem for patients and for the health care system. However the good news is that tools such as used in this study provided us with more accurate information about C. difficile infection than we've ever had before, and this is helping us improve our infection-prevention efforts and also analyze their cost-effectiveness"

David A Enoch, MRCPath, a consultant microbiologist at the Peterborough and Stamford Hospitals, (UK), commented in the same journal, “That prevention and strict control measures are important for controlling the spread of the disease. Adhering to basic evidence-based precautions can rapidly reduce the transmission of C. difficile and its associated mortality. Surveillance is essential to assess the efficacy of interventions. "The study was published in the December 2011 issue of the Canadian Medical Association Journal.

Related Links:

Ottawa Hospital
Ottawa Hospital Research Institute
Peterborough and Stamford Hospitals




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.